A recent study indicates that people who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle programs.
Published data in a prominent medical journal demonstrates that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users buying such drugs need to be informed of the potential of rapid weight regain when the medication concludes," warns expert Dr. Susan Jebb.
Such speed of regain means a return to original mass within about 18 months.
Analyzing Treatments
The analysis, which reviewed dozens of studies involving thousands of patients, contrasted the results of the injectable medications with other pills.
Scientists emphasize that individuals who lose weight through diet and exercise usually experience a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Rapid Regain
Doctors suggest the mechanism of the jabs accounts for the amplified weight return.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Sustained high doses of GLP-1 levels far above than normal may cause the system to produce less of its endogenous GLP-1, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.
"Stopping of this hormone supplement results in hunger is unsuppressed, making binge eating a significant risk."
A Chronic Condition?
The NHS recommend the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the therapy might need to be ongoing.
This opinion is reinforced by drug manufacturers, who state that the results "underscore the chronic nature of excess weight," comparing it to managing diseases like diabetes.
User Experiences
Users who have discontinued the medication describe a powerful return of hunger.
"I experienced a switch activating and you're instantly ravenous," said a patient.
The struggle is exacerbated if users have not developed permanent lifestyle or habit modifications during therapy.
Significant Interest
Survey data show that millions of people in the UK have tried these injections in the past year, with desire continuing to grow.
- Adoption is higher among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are potent tools for shedding pounds, they are not a magic fix and lasting health benefits hinges on ongoing lifestyle changes.
